Design, Synthesis and Pharmacological Evaluation of Naphthofuran Derivatives as Potent SIRT1 Activators
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design, Synthesis and Pharmacological Evaluation of Naphthofuran Derivatives as Potent SIRT1 Activators
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-28
DOI
10.3389/fphar.2021.653233
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma
- (2020) Ruosi Yao et al. Drug Design Development and Therapy
- P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy
- (2019) Fuzhe Ma et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming
- (2018) Agnes L.C. Ong et al. AGEING RESEARCH REVIEWS
- MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease
- (2018) Weiying Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21
- (2018) Ruosi Yao et al. EXPERIMENTAL HEMATOLOGY
- SRT2104 attenuates diabetes-induced aortic endothelial dysfunction via inhibition of P53
- (2018) Hao Wu et al. JOURNAL OF ENDOCRINOLOGY
- The role of the complement system in diabetic nephropathy
- (2017) Allan Flyvbjerg Nature Reviews Nephrology
- Tangshen formula improves inflammation in renal tissue of diabetic nephropathy through SIRT1/NF-κB pathway
- (2017) Yue‑Guang Du et al. Experimental and Therapeutic Medicine
- Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
- (2017) Xueling Li et al. Scientific Reports
- High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway
- (2015) Ling Zhou et al. Journal of Translational Medicine
- Crystallographic structure of a small molecule SIRT1 activator-enzyme complex
- (2015) Han Dai et al. Nature Communications
- Glomerular and Tubular Function in the Diabetic Kidney
- (2014) Roland C. Blantz et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- New Insights Into Molecular Mechanisms of Diabetic Kidney Disease
- (2014) Shawn S. Badal et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathway
- (2014) Rong Guo et al. Diabetes & Vascular Disease Research
- Transforming Growth Factor-β–Induced Cross Talk Between p53 and a MicroRNA in the Pathogenesis of Diabetic Nephropathy
- (2013) Supriya D. Deshpande et al. DIABETES
- Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man
- (2012) Ethan Hoffmann et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- NF-κB as a Target for Modulating Inflammatory Responses
- (2012) Chiara Gasparini et al. CURRENT PHARMACEUTICAL DESIGN
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Risk Factors for End-Stage Renal Disease
- (2009) Chi-yuan Hsu et al. ARCHIVES OF INTERNAL MEDICINE
- Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy
- (2008) Kulbhushan Tikoo et al. FREE RADICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started